Targeted to inhibit cox 2 cyclooxygenase 2 inhibitors. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy28

Seminal Vesicles Cells, Cultured Endothelium, Vascular Blood Platelets Microsomes Gastric Mucosa Arterioles Macrophages Muscle, Smooth, Vascular Mesenteric Arteries Cell Line Intestinal Mucosa Lung Aorta Kidney Fibroblasts Tumor Cells, Cultured Kidney Medulla Ductus Arteriosus Cell Line, Tumor Muscle, Smooth Synovial Membrane Epithelial Cells Aorta, Thoracic Macrophages, Peritoneal Endothelium Neutrophils Monocytes

Organisms11

Rats, Sprague-Dawley Sheep Rats, Wistar Mice, Inbred C57BL Rabbits Mice, Knockout Dogs Swine Guinea Pigs Cnidaria Rats, Inbred WKY

Diseases11

Inflammation Stomach Ulcer Disease Models, Animal Colonic Neoplasms Edema Osteoarthritis Adenocarcinoma Colorectal Neoplasms Cytochrome-c Oxidase Deficiency Gastrointestinal Diseases Hyperalgesia

Chemicals and Drugs157

Cyclooxygenase 2 Cyclooxygenase 1 Cyclooxygenase Inhibitors Cyclooxygenase 2 Inhibitors Prostaglandin-Endoperoxide Synthases Dinoprostone Indomethacin Prostaglandins Isoenzymes Arachidonic Acid Nitrobenzenes Anti-Inflammatory Agents, Non-Steroidal Lipoxygenase Inhibitors Sulfonamides Ibuprofen Pyrazoles Thromboxane B2 Membrane Proteins Arachidonic Acids Flurbiprofen 6-Ketoprostaglandin F1 alpha Lipoxygenase Eicosanoids Aspirin Epoprostenol Masoprocol Piroxicam Diclofenac Thromboxane A2 Intramolecular Oxidoreductases Receptors, Prostaglandin E Thromboxane-A Synthase Naproxen Arachidonate 5-Lipoxygenase Thiazines Hydroxyeicosatetraenoic Acids Thromboxanes Meclofenamic Acid Prostaglandins G Dinoprost 5,8,11,14-Eicosatetraynoic Acid 4,5-Dihydro-1-(3-(trifluoromethyl)phenyl)-1H-pyrazol-3-amine Sulfones Nitric Oxide Lactones Prostaglandins E Nitric Oxide Synthase Phospholipases A RNA, Messenger Phospholipases A2 Sulindac Enzyme Inhibitors Prostaglandin H2 Ketorolac Leukotrienes 8,11,14-Eicosatrienoic Acid Receptors, Prostaglandin E, EP4 Subtype Prostaglandin D2 Arachidonate Lipoxygenases Receptors, Thromboxane Receptors, Prostaglandin E, EP1 Subtype Bradykinin Leukotriene B4 Calcimycin Prostaglandin Antagonists Hydrazines Prostaglandins H Tolmetin Receptors, Prostaglandin E, EP2 Subtype Salicylates NG-Nitroarginine Methyl Ester Electron Transport Complex IV Nitric Oxide Synthase Type II Lipopolysaccharides Interleukin-1 Receptors, Prostaglandin Peroxidases 12-Hydroxy-5,8,10,14-eicosatetraenoic Acid Ketoprofen Vasodilator Agents Receptors, Prostaglandin E, EP3 Subtype 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid Nitroarginine Ketorolac Tromethamine Biological Factors Receptors, Thromboxane A2, Prostaglandin H2 Acetylcholine Vasoconstrictor Agents SRS-A Anti-Inflammatory Agents Phospholipases A2, Cytosolic Hydroxyprostaglandin Dehydrogenases Quinacrine Lipoxins Prostaglandins F Fatty Acids, Unsaturated NF-kappa B Sodium Salicylate Dexamethasone Isoxazoles Arachidonate 12-Lipoxygenase Free Radicals Group IV Phospholipases A2 Prostaglandins I Cytochrome P-450 Enzyme System Tumor Necrosis Factor-alpha Alprostadil Thiazoles omega-N-Methylarginine Acetaminophen Peroxides Autacoids Linoleic Acid Nitroprusside Receptors, Epoprostenol Lipid Peroxides Indoprofen Isoprostanes Proadifen Eicosanoic Acids Prostaglandin Endoperoxides, Synthetic Endothelium-Dependent Relaxing Factors Carrageenan Diflunisal Phospholipases Prostaglandins D Nitric Oxide Donors Prostaglandin Endoperoxides Inflammation Mediators Catechols Anticarcinogenic Agents Imidazoles Arachidonate 15-Lipoxygenase Platelet Activating Factor Zymosan Tetradecanoylphorbol Acetate Analgesics, Non-Narcotic Furans Cyclic AMP Peroxidase Arginine Calcium Endocannabinoids Interleukin-1beta p38 Mitogen-Activated Protein Kinases Dactinomycin Pyridines Nitric Oxide Synthase Type III Acetophenones Phenol Flavonoids Eicosapentaenoic Acid Hydrogen Peroxide Phenylephrine Reactive Oxygen Species Pyrazolones Indans

Analytical, Diagnostic and Therapeutic Techniques and Equipment19

Proportional Hazards Models Blotting, Western Immunohistochemistry Reverse Transcriptase Polymerase Chain Reaction Prognosis Risk Factors Disease Models, Animal Cohort Studies Survival Analysis Chromatography, High Pressure Liquid Blood Pressure Prospective Studies Follow-Up Studies Kaplan-Meier Estimate Survival Rate Retrospective Studies Analysis of Variance Treatment Outcome Multivariate Analysis

Phenomena and Processes26

Dose-Response Relationship, Drug Vasodilation Gene Expression Regulation, Enzymologic Enzyme Induction Vasoconstriction Time Factors Platelet Aggregation Signal Transduction Up-Regulation Kinetics Enzyme Activation Drug Interactions Blood Pressure Gene Expression Apoptosis Microcirculation Regional Blood Flow Vascular Resistance Pulmonary Circulation Cell Division Base Sequence Drug Synergism Muscle Contraction Oxidative Stress Gene Expression Regulation Muscle Relaxation

Disciplines and Occupations1

Immunohistochemistry

Information Science3

Survival Rate Base Sequence Molecular Sequence Data

Health Care12

Proportional Hazards Models Risk Factors Cohort Studies Survival Analysis Prospective Studies Follow-Up Studies Kaplan-Meier Estimate Survival Rate Retrospective Studies Analysis of Variance Treatment Outcome Multivariate Analysis

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Phenomena and Processes Disciplines and Occupations Information Science Health Care

Cyclooxygenase 2 Cyclooxygenase 1 Cyclooxygenase Inhibitors Cyclooxygenase 2 Inhibitors Prostaglandin-Endoperoxide Synthases Dinoprostone Indomethacin Prostaglandins Isoenzymes Arachidonic Acid Nitrobenzenes Anti-Inflammatory Agents, Non-Steroidal Lipoxygenase Inhibitors Sulfonamides Ibuprofen Pyrazoles Thromboxane B2 Membrane Proteins Arachidonic Acids Flurbiprofen 6-Ketoprostaglandin F1 alpha Lipoxygenase Eicosanoids Aspirin Epoprostenol Masoprocol Piroxicam Diclofenac Thromboxane A2 Intramolecular Oxidoreductases Receptors, Prostaglandin E Thromboxane-A Synthase Naproxen Arachidonate 5-Lipoxygenase Thiazines Hydroxyeicosatetraenoic Acids Thromboxanes Meclofenamic Acid Prostaglandins G Dinoprost Seminal Vesicles 5,8,11,14-Eicosatetraynoic Acid 4,5-Dihydro-1-(3-(trifluoromethyl)phenyl)-1H-pyrazol-3-amine Sulfones Nitric Oxide Lactones Prostaglandins E Dose-Response Relationship, Drug Vasodilation Nitric Oxide Synthase Gene Expression Regulation, Enzymologic Phospholipases A Proportional Hazards Models RNA, Messenger Enzyme Induction Phospholipases A2 Cells, Cultured Sulindac Enzyme Inhibitors Prostaglandin H2 Ketorolac Leukotrienes 8,11,14-Eicosatrienoic Acid Endothelium, Vascular Rats, Sprague-Dawley Vasoconstriction Receptors, Prostaglandin E, EP4 Subtype Prostaglandin D2 Arachidonate Lipoxygenases Receptors, Thromboxane Receptors, Prostaglandin E, EP1 Subtype Bradykinin Leukotriene B4 Calcimycin Prostaglandin Antagonists Hydrazines Prostaglandins H Tolmetin Receptors, Prostaglandin E, EP2 Subtype Salicylates Sheep Blood Platelets Rats, Wistar Blotting, Western NG-Nitroarginine Methyl Ester Electron Transport Complex IV Time Factors Nitric Oxide Synthase Type II Lipopolysaccharides Interleukin-1 Receptors, Prostaglandin Peroxidases 12-Hydroxy-5,8,10,14-eicosatetraenoic Acid Platelet Aggregation Ketoprofen Immunohistochemistry Vasodilator Agents Receptors, Prostaglandin E, EP3 Subtype 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid Nitroarginine

No FAQ available that match "targeted to inhibit cox 2 cyclooxygenase 2 inhibitors"